LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $309,786 | -18.5% | 5,170 | -1.9% | 0.07% | -50.7% |
| Q2 2023 | $379,895 | -39.5% | 5,269 | -38.3% | 0.14% | -57.9% |
| Q1 2023 | $627,835 | +95.9% | 8,535 | +77.9% | 0.34% | +113.8% |
| Q4 2022 | $320,440 | -64.4% | 4,797 | -54.1% | 0.16% | -49.5% |
| Q3 2022 | $900,000 | -3.4% | 10,450 | 0.0% | 0.32% | -22.1% |
| Q2 2022 | $932,000 | -20.7% | 10,450 | 0.0% | 0.41% | -26.0% |
| Q1 2022 | $1,176,000 | -27.3% | 10,450 | -0.2% | 0.55% | +103.0% |
| Q4 2021 | $1,618,000 | -0.7% | 10,473 | -10.5% | 0.27% | +105.3% |
| Q3 2021 | $1,630,000 | -9.2% | 11,700 | -14.5% | 0.13% | -41.6% |
| Q2 2021 | $1,796,000 | -27.9% | 13,689 | -16.2% | 0.23% | -45.7% |
| Q1 2021 | $2,490,000 | -68.1% | 16,332 | -79.2% | 0.42% | -47.2% |
| Q4 2020 | $7,805,000 | +97.4% | 78,478 | +89.2% | 0.79% | +109.0% |
| Q3 2020 | $3,954,000 | +64.2% | 41,485 | +92.7% | 0.38% | +140.1% |
| Q2 2020 | $2,408,000 | – | 21,531 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |